Current Neuro-Oncology
Volume
26 Number 6
31 March 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 6, 31 March
Jang B, Yoon D, Lee JY, Kim J, Hong J, Koo H, Sa JK.
Integrative
multi-omics characterization reveals sex differences in
glioblastoma.
Biol
Sex Differ. 2024 Mar 16;15(1):23. doi:
10.1186/s13293-024-00601-7. PMID:
38491408. Observational study.
ˍ
*Zhu P, Pichardo-Rojas PS, Dono A, Tandon N, Hadjipanayis CG,
Berger MS, Esquenazi Y.
The detrimental
effect of biopsy preceding resection in surgically accessible
glioblastoma: results from the national cancer database.
J
Neurooncol. 2024 Mar 16. doi:
10.1007/s11060-024-04644-z. PMID:
38492191. Observational study˰
ˍ
*Cao W, Lan J, Hu C, Kong J, Xiang L, Zhang Z, Sun Y, Zeng Z, Lei
S.
Predicting the prognosis of glioma
patients with TERT promoter mutations and guiding the specific
immune profile of immune checkpoint blockade therapy.
Aging
(Albany NY). 2024 Mar 18;16. doi:
10.18632/aging.205668. PMID:
38499392. Observational study.
ˍ
Nemati M, Shayanfar M, Almasi F, Mohammad-Shirazi M, Sharifi G,
Aminianfar A, Esmaillzadeh A.
Dietary
patterns in relation to glioma: a case-control study.
Cancer
Metab. 2024 Mar 18;12(1):8. doi:
10.1186/s40170-024-00336-4. PMID:
38500219. Observational study.
ˍ
Van Genechten T, De Laere M, Van den Bossche J, Stein B, De Rycke
K, Deschepper C, Hazes K, Peeters R, Couttenye MM, Van De Walle K,
Roelant E, Maes S, Vanden Bossche S, Dekeyzer S, Huizing M,
Caluwaert K, Nijs G, Cools N, Verlooy J, Norga K, Verhulst S,
Anguille S, Berneman Z, Lion E.
Adjuvant
Wilms' tumour 1-specific dendritic cell immunotherapy
complementing conventional therapy for paediatric patients with
high-grade glioma and diffuse intrinsic pontine glioma: protocol
of a monocentric phase I/II clinical trial in Belgium.
BMJ
Open. 2024 Mar 18;14(3):e077613. doi:
10.1136/bmjopen-2023-077613. PMID:
38503417. Interventional study protocol. ˍ
*Bobholz SA, Lowman AK, Connelly JM, Duenweg SR, Winiarz A, Nath
B, Kyereme F, Brehler M, Bukowy J, Coss D, Lupo JM, Phillips JJ,
Ellingson BM, Krucoff MO, Mueller WM, Banerjee A, LaViolette
PS.
Noninvasive Autopsy-Validated Tumor
Probability Maps Identify Glioma Invasion Beyond Contrast
Enhancement.
Neurosurgery.
2024 Mar 19. doi:
10.1227/neu.0000000000002898. PMID:
38501824. Observational study.
ˍ
Geens W, Vanlaer N, Nijland L, Van Laere S, Schwarze JK, Bruneau
M, Neyns B, Rogiers A, Duerinck J.
Health-related
quality of life and neurocognitive functioning in patients with
recurrent glioblastoma treated with intracerebral immune
checkpoint inhibition.
J
Neurooncol. 2024 Mar 19. doi:
10.1007/s11060-024-04646-x. PMID:
38502281. Observational study˰
ˍ
Roth P, Gorlia T, Reijneveld JC, de Vos F, Idbaih A, Frenel JS, Le
Rhun E, Sepulveda JM, Perry J, Masucci GL, Freres P, Hirte H,
Seidel C, Walenkamp A, Lukacova S, Meijnders P, Blais A, Ducray F,
Verschaeve V, Nicholas G, Balana C, Bota DA, Preusser M, Nuyens S,
Dhermain F, van den Bent M, O'Callaghan CJ, Vanlancker M, Mason W,
Weller M; EORTC Brain Tumor Group and the Canadian Cancer Trials
Group.
Marizomib for patients with
newly diagnosed glioblastoma: a randomized phase 3 trial.
Neuro
Oncol. 2024 Mar 19:noae053. doi:
10.1093/neuonc/noae053. PMID:
38502052. Interventional study. ˍ
*Fairclough S, Chumas P, Goodden J, Maguire M, Mathew RK.
Motor
seizures confer overall survival benefit in who grade 2
glioma.
Epilepsia.
2024 Mar 20. doi:
10.1111/epi.17956. PMID:
38506645. Observational study.
ˍ
*Fink L, van Oorschot B, von Saß C, Dibué M, Foster
MT, Golla H, Goldbrunner R, Senft C, Lawson McLean A, Hellmich M,
Dinc N, Voltz R, Melching H, Jungk C, Kamp MA.
Palliative
care for in-patient malignant glioma patients in Germany.
J
Neurooncol. 2024 Mar 20. doi:
10.1007/s11060-024-04611-8. PMID:
38506960. Observational study.
ˍ
Li MP, Yeo A, Gunewardena R, Drum G, Wiltshire K, Phillips C, Sia
J, Wheeler G, Hall L.
Is proton beam
therapy always better than photon irradiation? Lessons from two
cases.
J
Med Radiat Sci. 2024 Mar 20. doi:
10.1002/jmrs.773. PMID:
38504608. Case report. ˍ
Rejimon AC, Ramesh KK, Trivedi AG, Huang V, Schreibmann E,
Weinberg BD, Kleinberg LR, Shu HG, Shim H, Olson JJ.
The
Utility of Spectroscopic MRI in Stereotactic Biopsy and
Radiotherapy Guidance in Newly Diagnosed Glioblastoma.
Tomography.
2024 Mar 20;10(3):428-443. doi:
10.3390/tomography10030033. PMID:
38535775. Observational study.
ˍ
*Ryba A, Özdemir Z, Nissimov N, Hönikl L, Neidert N,
Jakobs M, Kalasauskas D, Krigers A, Thomé C, Freyschlag CF,
Ringel F, Unterberg A, Dao Trong P, Beck J, Heiland DH, Meyer B,
Vajkoczy P, Onken J, Stummer W, Suero Molina E, Gempt J, Westphal
M, Schüller U, Mohme M.
Insights
from a Multicenter Study on Adult H3 K27M-Mutated Glioma: Surgical
Resection's Limited Influence on Overall Survival, ATRX as
Molecular Prognosticator.
Neuro
Oncol. 2024 Mar 20:noae061. doi:
10.1093/neuonc/noae061. PMID:
38507506. Observational study˰
ˍ
*Wang J, Du Q, Chen J, Liu J, Gu Z, Wang X, Zhang A, Gao S, Shao
A, Zhang J, Wang Y.
Tumor treating
fields in glioblastoma: long-term treatment and high compliance as
favorable prognostic factors.
Front
Oncol. 2024 Mar 20;14:1345190. doi:
10.3389/fonc.2024.1345190. PMID:
38571508. Observational study. ˍ
Gull HH, Von Riegen AC, Beckmann GT, Ketelauri P, Walbrodt S,
Santos AN, Oster C, Schmidt T, Glas M, Jabbarli R, Özkan N,
Dammann P, Scheffler B, Sure U, Ahmadipour Y.
Treatment
Strategies for Glioblastoma in the Elderly: What Should We Focus
on Compared to Younger Patients.
Cancers
(Basel). 2024 Mar 21;16(6):1231. doi:
10.3390/cancers16061231. PMID:
38539563. Observational study.
ˍ
Kim D, Lee JH, Kim N, Lim DH, Song JH, Suh CO, Wee CW, Kim
IA.
Optimizing Recurrent Glioblastoma
Salvage Treatment: A Multicenter Study Integrating Genetic
Biomarkers From the Korean Radiation Oncology Group
(21-02).
Neurosurgery.
2024 Mar 21. doi:
10.1227/neu.0000000000002903. PMID:
38511935. Observational study˰
ˍ
*Fernández-Valverde F, Bautista-Bárcena MP,
Roldán-Romero E, Solivera-Vela J, Bravo-Rodríguez F,
Ramos-Gómez MJ.
Prognostic value
of brain perfusion by MRI in the initial study of high grade
gliomas.
Radiologia
(Engl Ed). 2024 Mar 22;66(2):114-120. doi:
10.1016/j.rxeng.2022.12.010. PMID:
38614528. Observational study˰
ˍ
Picca A, Touat M, Belin L, Gourmelon C, Harlay V, Cuzzubbo S,
Cohen-Jonathan Moyal E, Bronnimann C, Di Stefano AL, Laurent I,
Lerond J, Carpentier C, Bielle F, Ducray F, Dehais C; POLA
Network.
REVOLUMAB: A phase II trial of
nivolumab in recurrent IDH mutant high-grade gliomas.
Eur
J Cancer. 2024 Mar 22;202:114034. doi:
10.1016/j.ejca.2024.114034. PMID:
38537315. Interventional study˰
ˍ
*Straube C, Combs SE, Bernhardt D, Gempt J, Meyer B, Zimmer C,
Schmidt-Graf F, Vajkoczy P, Grün A, Ehret F, Zips D, Kaul
D.
Adjuvant re-irradiation vs. no early
re-irradiation of resected recurrent glioblastoma: pooled
comparative cohort analysis from two tertiary centers.
J
Neurooncol. 2024 Mar 23. doi:
10.1007/s11060-024-04633-2. PMID:
38520571. Observational study.
ˍ
Desai PB, Karve A, Zawit M, Arora P, Dave N, Awosika J, Li N,
Fuhrman B, Medvedovic M, Sallans L, Kendler A, DasGupta B, Plas D,
Curry R, Zuccarello M, Chaudhary R, Sengupta S, Wise-Draper TM.
A
Phase 0/1 Pharmacokinetic and Pharmacodynamics and Safety and
Tolerability Study of Letrozole in Combination with Standard
Therapy in Recurrent High-rade Gliomas.
Clin
Cancer Res. 2024 Mar 26. doi:
10.1158/1078-0432.CCR-23-3341. PMID:
38530160. Interventional study˰
ˍ
Mak LS, Li X, Chan WYK, Leung AWK, Cheuk DKL, Yuen LYP, So JCC, Ha
SY, Liu APY.
Case report:
Therapy-related myeloid neoplasms in three pediatric cases with
medulloblastoma.
Front
Oncol. 2024 Mar 26;14:1364199. doi:
10.3389/fonc.2024.1364199. PMID:
38595820. Case report. ˍ
Meel M, Jindal A, Kumar M, Mathur K, Singh A.
IDH1,
ATRX, p53, and Ki67 Expression in
Glioblastoma patients: Their Clinical and Prognostic
Significance-A Prospective Study.
Asian
J Neurosurg. 2024 Mar 26;19(1):14-20. doi:
10.1055/s-0042-1750783. PMID:
38751398. Observational study. ˍ
Phillips MCL, Thotathil Z, Dass PH, Ziad F, Moon BG.
Ketogenic
metabolic therapy in conjunction with standard treatment for
glioblastoma: A case report.
Oncol
Lett. 2024 Mar 26;27(5):230. doi:
10.3892/ol.2024.14363. PMID:
38586213. Case report. ˍ
Wellbrock M, Voigt M, Ronckers C, Grabow D, Spix C, Erdmann
F.
Registration, incidence patterns,
and survival trends of central nervous system tumors among
children in Germany 1980-2019: An analysis of 40 years based on
data from the German Childhood Cancer Registry.
Pediatr
Blood Cancer. 2024 Mar 26:e30954. doi:
10.1002/pbc.30954. PMID:
38532243. Observational study.
ˍ
Alcazar-Felix RJ, Srinath A, Hage S, Bindal A, Ressler A, Pytel P,
Allaw S, Girard R, Marchuk DA, Awad IA, Polster SP.
Pathologic
Features of Brain Hemorrhage After Radiation Treatment: Case
Series with Somatic Mutation Analysis.
J
Stroke Cerebrovasc Dis. 2024 Mar 27:107699. doi:
10.1016/j.jstrokecerebrovasdis.2024.107699. PMID:
38552890. Observational study˰
ˍ
*Duffau H.
Case report: when art is
faced with brain surgery: acute change in creative style in a
painter after glioma resection.
Front
Oncol. 2024 Mar 28;14:1394609. doi:
10.3389/fonc.2024.1394609. PMID:
38606096. Case report. ˍ
*Qin Z, Yang B, Jin X, Zhao H, Liu N.
Cuproptosis
in glioblastoma: unveiling a novel prognostic model and
therapeutic potential.
Front
Oncol. 2024 Mar 28;14:1359778. doi:
10.3389/fonc.2024.1359778. PMID:
38606090. Laboratory investigation. ˍ
Troschel FM, Troschel BO, Kloss M, Jost J, Pepper NB,
Völk-Troschel AS, Wiewrodt RG, Stummer W, Wiewrodt D, Eich
HT.
Sarcopenia is associated with
chemoradiotherapy discontinuation and reduced progression-free
survival in glioblastoma patients.
Strahlenther
Onkol. 2024 Mar 28. doi:
10.1007/s00066-024-02225-7. PMID:
38546749. Observational study.
ˍ
Evans L, Walker R, MacDiarmid J, Brahmbhatt H, Anazodo A, McCowage
G, Gifford AJ, Kavallaris M, Trahair T, Ziegler DS.
A
Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with
Solid or CNS Tumours Expressing Epidermal Growth Factor
Receptor.
Target
Oncol. 2024 Mar 28. doi:
10.1007/s11523-024-01051-2. PMID:
38546944. Interventional study.
ˍ
Tong E, Horsley P, Wheeler H, Wong M, Venkatesha V, Chan J,
Kastelan M, Back M.
Hypofractionated
re-irradiation with bevacizumab for relapsed chemorefractory
glioblastoma after prior high dose radiotherapy: a feasible option
for patients with large-volume relapse.
J
Neurooncol. 2024 Mar 29. doi:
10.1007/s11060-024-04643-0. PMID:
38551747. Observational study˰
ˍ
Juarez TM, Gill JM, Heng A, Carrillo JA, Wagle N, Nomura N, Nguyen
M, Truong J, Dobrawa L, Sivakumar W, Barkhoudarian G, Kelly DF,
Kesari S.
A phase I dose-escalation
study of pulsatile afatinib in patients with recurrent or
progressive brain cancer.
Neurooncol
Adv. 2024 Mar 30;6(1):vdae049. doi:
10.1093/noajnl/vdae049. PMID:
38680990. Interventional study. ˍ
Barnett AE, Ozair A, Bamashmos AS, Li H, Bosler DS, Yeaney G, Ali
A, Peereboom DM, Lathia JD, Ahluwalia MS.
MGMT
Methylation and Differential Survival Impact by Sex in
Glioblastoma.
Cancers
(Basel). 2024 Mar 31;16(7):1374. doi:
10.3390/cancers16071374. PMID:
38611052. Observational study. ˍ
Bieth T, Facque V, Altmayer V, Poisson I, Ovando-Tellez M,
Moreno-Rodriguez S, Lopez-Persem A, Mandonnet E, Volle E.
Impaired
creative cognition after surgery for an IDH-mutated glioma: A
proof-of-concept study.
Cortex.
2024 Mar 31;174:219-233. doi:
10.1016/j.cortex.2024.02.017. PMID:
38593576.. Observational study. ˍ